These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15866671)
1. Hemopoietic stem cell transplantation in childhood: reduction in mortality and improvement of survival over the years. Espigado I; Marín-Niebla A; Pérez-Hurtado JM; Ríos E; Carmona M; Plaza E; Vaquero A; Campo T; Pérez de Soto I; Martino ML; Parody R; Rodríguez-Fernández JM Transplant Proc; 2005 Apr; 37(3):1555-6. PubMed ID: 15866671 [TBL] [Abstract][Full Text] [Related]
2. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358 [TBL] [Abstract][Full Text] [Related]
3. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience. Martins C; Lacerda JF; Lourenço F; Carmo JA; Lacerda JM Acta Med Port; 2005; 18(5):329-37. PubMed ID: 16611537 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of peripheral blood stem cell transplantation from mismatched related and unrelated donors. Blau IW; Schmidt-Hieber M; Basara N; Hopfenmüller W; Bischoff M; Günzelmann S; Kirsten D; Schmetzer B; Roemer E; Kiehl MG; Thiel E; Fauser AA Clin Transplant; 2007; 21(1):110-6. PubMed ID: 17302599 [TBL] [Abstract][Full Text] [Related]
5. Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia. Anagnostopoulos A; Hari PN; Pérez WS; Ballen K; Bashey A; Bredeson CN; Freytes CO; Gale RP; Gertz MA; Gibson J; Goldschmidt H; Lazarus HM; McCarthy PL; Reece DE; Vesole DH; Giralt SA Biol Blood Marrow Transplant; 2006 Aug; 12(8):845-54. PubMed ID: 16864055 [TBL] [Abstract][Full Text] [Related]
7. Myeloablative allogeneic stem cell transplantation for advanced stage multiple myeloma: very long-term follow up of a single center experience. Kennedy GA; Butler J; Morton J; Hill G; Western R; Cummings J; Allison R; Durrant S Clin Lab Haematol; 2006 Jun; 28(3):189-97. PubMed ID: 16706936 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities. van der Straaten HM; van Biezen A; Brand R; Schattenberg AV; Egeler RM; Barge RM; Cornelissen JJ; Schouten HC; Ossenkoppele GJ; Verdonck LF; Haematologica; 2005 Oct; 90(10):1339-45. PubMed ID: 16219570 [TBL] [Abstract][Full Text] [Related]
11. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801 [TBL] [Abstract][Full Text] [Related]
12. Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation. Dahlke J; Kröger N; Zabelina T; Ayuk F; Fehse N; Wolschke C; Waschke O; Schieder H; Renges H; Krüger W; Kruell A; Hinke A; Erttmann R; Kabisch H; Zander AR Bone Marrow Transplant; 2006 Jan; 37(2):155-63. PubMed ID: 16284608 [TBL] [Abstract][Full Text] [Related]
13. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial. Ribera JM; Ortega JJ; Oriol A; Bastida P; Calvo C; Pérez-Hurtado JM; González-Valentín ME; Martín-Reina V; Molinés A; Ortega-Rivas F; Moreno MJ; Rivas C; Egurbide I; Heras I; Poderós C; Martínez-Revuelta E; Guinea JM; del Potro E; Deben G J Clin Oncol; 2007 Jan; 25(1):16-24. PubMed ID: 17194902 [TBL] [Abstract][Full Text] [Related]
14. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Ribera JM; Oriol A; Bethencourt C; Parody R; Hernández-Rivas JM; Moreno MJ; del Potro E; Torm M; Rivas C; Besalduch J; Sanz MA; Ortega JJ; Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of up-front treatment with a double stem cell transplantation in multiple myeloma. Eom KS; Min CK; Lee S; Kim YJ; Kim SY; Kim HJ; Lee JW; Min WS; Kim CC Jpn J Clin Oncol; 2006 Jul; 36(7):432-8. PubMed ID: 16782727 [TBL] [Abstract][Full Text] [Related]
16. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients. Schmid I; Stachel D; Pagel P; Albert MH Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786 [TBL] [Abstract][Full Text] [Related]
17. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin. Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372 [TBL] [Abstract][Full Text] [Related]